CALLABLE MULTI DEFENDER VONTI - ROCHE GS/GALENICA/LONZA GROUP Share Price

Certificat

RMAEXV

CH1211055368

Real-time Bid/Ask 15:24:38 10/05/2024 BST
101.1 CHF / 101.9 CHF +0.40% Intraday chart for CALLABLE MULTI DEFENDER VONTI - ROCHE GS/GALENICA/LONZA GROUP
1 month+0.80%
3 months+4.23%

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
RMAEXV
ISINCH1211055368
Date issued 11/11/2022
Strike 325.6 CHF
Maturity 13/05/2024 (3 Days)
Parity 0.33 : 1
Emission price 100 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 103.9 CHF
Lowest since issue 84.9 CHF
Spread 8 CHF
Spread %0.79%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
222.3 CHF
Average target price
279.4 CHF
Spread / Average Target
+25.68%
Consensus
  1. Stock Market
  2. Certificates
  3. RMAEXV Certificat